Nanoparticles can be engineered to target specific cancer cells, deliver drugs, or even act as imaging agents. Their small size allows them to penetrate tumors more effectively than conventional therapies. Additionally, nanoparticles can be functionalized with targeting molecules, such as antibodies or ligands, to bind specifically to cancer cells, thereby reducing off-target effects and enhancing therapeutic outcomes.
